iPhone | iPad
Android
Huawei
Referees have also been encouraged to identify players who are fasting prior to kickoff
KT APPDOWNLOAD
EU recommends Merck anti-Covid pill for adults at risk of severe illness
Advised against use during pregnancy for in women who plan to get pregnant.
AFP file
The European Union's drug regulator on Friday advised that an experimental Covid-19 pill from Merck should be given within five days of first symptoms to treat adults who do not need oxygen support and are at risk of their disease worsening.
The European Medicines Agency (EMA) said the pill, developed along with Ridgeback Biotherapeutics, should be taken twice a day for five days, but advised against use during pregnancy for in women who plan to get pregnant.
"EMA issued this advice to support national authorities who may decide on possible early use of the medicine prior to marketing authorisation ... in light of rising rates of infection and deaths due to Covid-19 across the EU," it said.
ALSO READ:
EMA began a rolling review of the Merck tablet, Lagevrio, last month, and on Friday also started looking at data on a rival pill from Pfizer Inc to make recommendations on its use, like that for Merck's, before wider approvals.
The regulator on Friday also said that breastfeeding must also be stopped around the time of treatment with Merck's Lagevrio.
More news from
Kingdom's Supreme Court had earlier called on Muslims to report the sighting of crescent either by the naked eye or through binoculars
People appearing on the screen sing praises of mothers, who can be seen getting overwhelmed and bursting into tears
India's top order batsmen were given a torrid time by Mitchell Starc who took eight wickets in the first two matches with his pace and swing
US crude and product stocks expected to drop in weekly reports
Multi-storey parking will operate all seven days of the week
Lifestyle influencer Ken Doll, painter
Specially designed packages to help enhance the ability to work during fasting hours